A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

structure, and molecular profile information of disease-relevant targets – as well as the criteria that make for a successful antibody molecule, like affinity, specificity, and developability ...

Pfizer chairman and CEO Albert Bourla sees cancer as Pfizer's next big chance to save the world. The complexity of cancers makes treatments expensive to develop and challenging to customize, but the ...

Ideally, the reactants should function similar to an antibody ... of a chemical reporter to a biomolecule, particularly in living organisms. Even subtle perturbations to the structure of a protein ...

A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

BENGALURU: When the first outbreak happened in Pune, all heads turned and started to panic. What was this new infectious ...

The research team, studying the efficacy of a preventive antibody-based therapy, found it successfully protects monkeys from ...